Immucell (ICCC) FCF Margin Growth (3y) (2013 - 2025)
Immucell (ICCC) FCF Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4,612.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1,850.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 14,060.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -3,088.00 |
| 10 | Immucell | 91.19 Mn | 82.33 Mn | 2.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9,169.00 |
| Sep 30, 2025 | 928.00 |
| Jun 30, 2025 | 3,720.00 |
| Mar 31, 2025 | 1,825.00 |
| Dec 31, 2024 | 552.00 |
| Sep 30, 2024 | -402.00 |
| Jun 30, 2024 | 78,535.00 |
| Mar 31, 2024 | 2,848.00 |
| Sep 30, 2023 | 4,030.00 |
| Jun 30, 2023 | -3,620.00 |
| Mar 31, 2023 | -9,189.00 |
| Dec 31, 2022 | -5,097.00 |
| Sep 30, 2022 | -2,584.00 |
| Jun 30, 2022 | 135.00 |
| Mar 31, 2022 | -1,376.00 |
| Dec 31, 2021 | 593.00 |
| Sep 30, 2021 | 2,543.00 |
| Jun 30, 2021 | 68,628.00 |
| Mar 31, 2021 | 976.00 |
| Dec 31, 2020 | 13,542.00 |